Viewing data from:

PBZ

ANDA

TRIPELENNAMINE HYDROCHLORIDE | A083149 | NOVARTIS PHARMACEUTICALS CORP

1 strength0 unique patents0 unique exclusivities

API Supply Chain0 active DMFs1 inactive

0 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

SCHUTZ AND COInactiveTRIPELENNAMINE HYDROCHLORIDE

DMF 105821993

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 25MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.